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Abstract: 
Objective: To evaluate the glucose tolerance in patients with chronic liver disease. 
Patients and Methods: This cross sectional study of six months was conducted at tertiary care hospital and studied 
the demographical and clinical manifestations and OGTT in thirty patients with chronic liver disease. The inclusion 
criteria were the patients diagnosed with chronic liver disease between the age group 12-60 years of either gender. 
All the relevant patients should have detail history, clinical examination and advised fasting and random blood 
sugar level and the oral glucose tolerance test accordingly while the response of test was also observed. The 
frequency and percentages was calculated while the numerical statistics were used to compute mean ±SD. 
Results: During six months study period total thirty patients with chronic liver diseases were recruited, enrolled and 
evaluate for the glycemic status. The mean age ±SD for whole population was 47.53±5.82 years, of thirty 
individuals 17 (56.6%) were males and 13 (43.3%) were females. The common etiologies detected for chronic liver 
disease were Hepatitis B (30%), hepatitis C (33.3%), hepatitis B & C (10%), alcoholic liver disease (10%) and 
hepatoma (10%). The OGTT response revealed as normal 16 (53.3%), impaired glucose tolerance 08 (26.6%) and 
diabetes mellitus 06 (20%) respectively.    
Conclusion: The positive correlation between chronic liver disease and glucose tolerance. Thus, the impaired 
glucose response is most common in liver cirrhosis. 
Keywords: Oral glucose tolerance test, chronic liver disease, Liver cirrhosis, impaired glucose tolerance and 
Diabetes Mellitus. 
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INTRODUCTION:  
The liver plays major role in blood sugar monitoring 
and not surprising that errors of CHO metabolism 
detected in chronic liver disease as liver cirrhosis, 
chronic hepatitis, hepatoma, etc [1, 2]. Metabolic 
abnormalities are found in subjects with late stage 
liver disease and the manifestation varies in relation 
to etiologic insult [3]. The liver maintains normal 
blood glucose level gluconeogenesis, glycogenesis 
and glycogenolysis. The metabolic alterations in liver 
cirrhosis are complex and not fully known and 
understand [4]. In fulminant acute hepatic failure the 
blood sugar levels may be low but is rarely seen in 
CLD. In fasted subjects with liver cirrhosis the 
contributions of CHO to generate energy is reduced 
to 3% as compared to control 40%) with 
contributions of fat increasing 87% as compared to 
control 40% [5]. This might be due to impaired 
hepatic glucose release or reduced glycogen storage 
in liver [6]. However in cirrhosis fallowing glucose 
load or meal there is raised blood sugar level 
(hyperglycemia) due to inability of liver to 
metabolize glucose, probably because of insulin 
resistance [7]. Cirrhotic patients have raised serum 
lactate levels reveals decrease hepatic capacity to 
utilize lactate for gluconeogenesis [8].  
Diabetes is also associated with chronic viral 
hepatitis C virus infection and disturbances of 
carbohydrate metabolism in hepatic disorders were 
directly proportional to the degree of hepatocellular 
damage [9]. Oral glucose tolerance test (OGTT) can 
be used for evaluating the hepatic glucose 
homeostatic power in chronic liver disease where the 
storage function reduced [10]. OGTT is superior to 
intravenous GTT because glucose is presented to 
body through a natural route and normal stimulation 
of insulin secretion by different hormones of GIT.  
Thus, this study was conducted to evaluate the status 
of blood sugar level and response of OGTT in 
patients with chronic liver disease. 
 
PATIENTS AND METHODS: 
 This cross sectional study of six months was 
conducted at tertiary care hospital and studied the 
demographical and clinical manifestations and OGTT 
in thirty patients with chronic liver disease. The 
inclusion criteria were the patients diagnosed with 
chronic liver disease between the age group 12- 60 
years of either gender while the exclusion criteria 
were know diabetes mellitus already on treatment, 
pregnant ladies, the patients had connective tissue / 
autoimmune disorders and other evidence like history 
of taking drugs and other causes that interfere the 
glucose homeostasis were excluded. All the relevant 
patients should have detail history, clinical 
examination and advised fasting and random blood 
sugar level and the oral glucose tolerance test 
accordingly while the response of test was also 
observed. The informed consent was taken and the 
data was collected and analyzed in SPSS version 16. 
The frequencies, percentages and means ±SD were 
computed. 
 
RESULTS:  
During six months study period total thirty patients 
with chronic liver diseases were recruited, enrolled 
and evaluate for the glycemic status. The mean age 
±SD for whole population was 47.53±5.82 years, of 
thirty individuals 17 (56.6%) were males and 13 
(43.3%) were females. The demographical, clinical 
and response of OGTT for the patients with chronic 
liver disease are shown in Table 1-2. 
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TABLE 01: THE DEMOGRAPHICAL AND CLINICAL PROFILE OF THE PATIENTS 
AGE (years) FREQUENCY (N=30) PERCENTAGE (%) 
12-19 02 6.6 
20-29 06 20 
30-39 09 30 
40-49 06 20 
50-59 05 16.6 
60 02 6.6 
   
GENDER   
Male 17 56.6 
Female 13 43.3 
   
RESIDENCE   
Urban 12 40 
Rural 18 60 
   
Etiology of chronic liver disease   
Hepatitis B 09 30 
Hepatitis C 10 33.3 
Hepatitis B & C 03 10 
Alcoholic liver disease 03 10 
Hepatoma 03 10 
Non alcoholic fatty liver disease 02 6.6 
   
Child-Pugh class   
A 10 33.3 
B 18 60 
C 02 6.6 
 
TABLE 02: THE RESPONSE OF ORAL GLUCOSE TOLERANCE TEST 
Oral glucose tolerance test (OGTT) Frequency (N=30) Percentage (%) 
Normal 16 53.3 
Impaired glucose tolerance 08 26.6 
Diabetes mellitus 06 20 
 
DISCUSSION:  
The liver functions to maintain normal blood glucose 
by different metabolic pathways, although it has been 
presumed that sensitivity of liver cells to insulin is 
responsible for the oral glucose uptake load by the 
liver, the literature mentioned the importance of 
insulin mediated glucose uptake by the liver cells [11, 
12] In the fasting state, the liver reveals glucose 
homeostasis by gluconeogenesis & glycogenolysis in 
response to hypoinsulinemia & hyperglucoganemia 
[13-15]. In present study the mean age was 47.53 ± 
5.82 years and correlated correlates to the study by 
Amarapurkar D, et al [16] as 45.93 ± 3.73 and also 
the gender ratio of current study correlates with that 
of Amarapurkar D, et al [16] study had male gender 
preponderance. The diabetic, IGT and normal 
responses are seen 20%, 26.6% and 53.3% 
respectively which correlates to the study by 
Majumdar G, et al (20%, 22.3% & 58%) [17]. Mild 
to moderate impaired glucose response is seen in 
35% in the studied by Megyesi C, et al [18] while the 
diabetic response was seen in 50% alcoholic cirrhosis 
studied by Kruszynska YT [19]. Thus, the findings of 
present study also consistent with the relevant former 
studies [20, 21]. In current series, cirrhosis due to 
chronic viral hepatitis is the most common (73.3%) 
etiology to impaired glucose response; this correlates 
with 18% impaired response observed by Megyesi C, 
et al [18]. In current study alcoholic liver disease and 
NAFLD, cause impaired response in 4% & 14% 
respectively, while in study by Majumdar G et al [17] 
alcohol liver disease and NAFLD are most common 
causes for impaired response as 18% each whereas 
the chronic cholestatic disorders not included in study 
but contributes to impaired glycemic response in the 
study by Majumdar G, et al [17]. Approximately 80% 
of individuals with liver cirrhosis shown glucose 
intolerance & 10-20% of them had diabetes mellitus 
[17]. The huge prevalence of diabetes mellitus has 
been reported in chronic viral hepatitis patients as 
compared to etiologies, thus both insulin resistance & 
impaired insulin secretion has been known to play a 
major role in the pathogenesis of diabetes mellitus in 
patients with chronic liver disease [22, 23]. The 
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insulin resistance & type 2 diabetes mellitus are are 
associated with HCV infection and along with 
interferon therapy (IFN α) may contribute to the 
development of type 2 and type 1 diabetes mellitus 
by several mechanisms as chemokines, 
proinflammatory cytokines & other immune 
mediated processes  that can worsen the outcomes in 
patients with HCV infection [24, 25]. 
 
CONCLUSION: 
The present study concluded the positive correlation 
between chronic liver disease and glucose tolerance. 
The impaired glucose response is most common in 
liver cirrhosis especially due to viral etiologies with 
male gender predominance whereas paradox response 
as fasting hypoglycemic status was observed in 
cirrhotic individuals with hepatoma. 
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